Onex Canada Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-21,935
Closed -$1.78M 122
2023
Q4
$1.78M Sell
21,935
-6,699
-23% -$521K 0.18% 119
2023
Q3
$2.15M Sell
28,634
-4,053
-12% -$312K 0.16% 121
2023
Q2
$2.52M Sell
32,687
-5,377
-14% -$429K 0.15% 120
2023
Q1
$3.16M Sell
38,064
-33,103
-47% -$2.74M 0.17% 116
2022
Q4
$6.11M Buy
71,167
+1,514
+2% +$120K 0.34% 87
2022
Q3
$4.3M Sell
69,653
-683
-1% -$43.1K 0.26% 96
2022
Q2
$4.35M Sell
70,336
-740
-1% -$45.8K 0.24% 98
2022
Q1
$4.22M Buy
71,076
+9,448
+15% +$604K 0.18% 113
2021
Q4
$4.47M Buy
61,628
+5,185
+9% +$357K 0.18% 123
2021
Q3
$3.94M Buy
56,443
+88
+0.2% +$6.18K 0.16% 130
2021
Q2
$3.88M Buy
56,355
+1,660
+3% +$111K 0.18% 115
2021
Q1
$3.54M Buy
54,695
+8,648
+19% +$558K 0.16% 129
2020
Q4
$2.68M Sell
46,047
-519
-1% -$31.3K 0.18% 109
2020
Q3
$2.94M Sell
46,566
-493
-1% -$34.2K 0.19% 103
2020
Q2
$3.62M Sell
47,059
-3,060
-6% -$235K 0.24% 95
2020
Q1
$3.75M Sell
50,119
-42,467
-46% -$2.93M 0.25% 95
2019
Q4
$5.89M Sell
92,586
-653
-0.7% -$42.5K 0.33% 86
2019
Q3
$5.91M Sell
93,239
-161,006
-63% -$10.5M 0.37% 83
2019
Q2
$17.2M Sell
254,245
-608
-0.2% -$40K 1.03% 38
2019
Q1
$16.6M Buy
254,853
+79,353
+45% +$5.27M 0.98% 39
2018
Q4
$11M Buy
+175,500
New +$12.3M 0.71% 45
2014
Q2
Sell
-392,460
Closed -$27.8M 82
2014
Q1
$27.8M Buy
392,460
+301,930
+334% +$23.7M 1.78% 20
2013
Q4
$6.8M Buy
90,530
+36,580
+68% +$2.55M 0.37% 61
2013
Q3
$3.39M Buy
+53,950
New +$3.22M 0.21% 82

Other funds holding GILD

Onex Canada Asset Management's GILD Position: Q1 2024 in Review

Onex Canada Asset Management sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 21,935 shares — an estimated $1.78M sold.

Onex Canada Asset Management first reported a position in GILD in Q3 2013 and held it in 24 quarters. The position peaked at $27.8M in Q1 2014. 1,721 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

  • Onex Canada Asset Management reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
  • Onex Canada Asset Management sold 21,935 Gilead Sciences shares in Q1 2024, an estimated $1.78M.
  • Onex Canada Asset Management first reported a position in Gilead Sciences in Q3 2013 and held it in 24 quarters.
  • Onex Canada Asset Management's Gilead Sciences position peaked at $27.8M in Q1 2014.
  • 1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on Onex Canada Asset Management's 13F filing for Q1 2024, filed 15 May 2024.